The fragile X syndrome is an X linked, semidominant mental retardation disorder caused by the amplification of a CGG repeat in the 5' UTR of the FMR1 gene. Nineteen fragile X families in which the mutated FMR1 gene segregated were evaluated. The implications ofthe diagnosis for the parents and family were studied through pedigree information, interviews, and questionnaires.
Information about the heredity of fragile X syndrome was only disseminated by family members to a third (124/366) of the relatives with an a priori risk of being a carrier ofthe fragile X syndrome. Twentysix percent (94/366) of the relatives were tested. Transmission of information among first degree relatives seemed satisfactory but dropped off sharply with increasing distance of the genetic relationship, leaving 66% uninformed. This is particularly disadvantageous in an X linked disease. Of those subjects tested, 42% (39/94) had a premutation and 18% (17/94 ) had a full mutation. On average, in each family one new fragile X patient and two new carriers were found.
When people have the task of transmitting genetic information to their relatives, they usually feel responsible and capable; however, reduced acquaintance and contact with more distant relatives severely reduces the effectiveness of such transfer of information in fragile X families. The fragile X syndrome is a common cause of familial mental retardation with an estimated prevalence of 1/4000-1/6000 for males in western countries.1-3 The main clinical features in males are mental retardation, macroorchidism, and a long, narrow face with large everted ears. [4] [5] [6] The mutation involved in this X linked disorder is characterised by the amplification of a trinucleotide (CGG) repeat in the 5' UTR of the FMR1 gene.7 8 Normal persons have between six and 54 CGG repeats, phenotypically normal carriers of the premutation have between 52 and 200, and affected subjects have more than 200 CGG repeats in their FMR1 gene, the so called full mutation.9 The cloning of the FMR1 gene in 1991 made determination of carrier status by DNA mutation analysis in both males and females possible.'"
The fragile X syndrome is an X linked recessive disorder with some special features; 52-82% of the carrier females with a full mutation show mental impairment"-'3 and males can also be carriers of the premutation. These so called "normal transmitting males"'4 can transmit the premutation through phenotypically normal daughters to their grandchildren who are at risk of being affected. A diagnosis of fragile X in a mentally retarded subject will allow better support of behavioural and psychological problems related to the fragile X syndrome. '5 16 However, the diagnosis also has far reaching implications for the parents of an affected subject, such as considerations regarding future offspring. Furthermore, it may be relevant to inform relatives about the hereditary aspects of the fragile X syndrome. So far, few reports have studied the impact of the fragile X diagnosis on parents and family and the effectiveness of disclosure of information to relatives. Other studies on informing the family through relatives, such as in cystic fibrosis '7 18 or balanced chromosomal translocations, [19] [20] [21] have shown the general ineffectiveness and problems of such an approach.
We studied the implications for parents and family after a diagnosis of the fragile X syndrome. Parental adjustment, the dissemination of information in the family, and the uptake of genetic counselling or DNA testing by family members at risk for being a carrier of the fragile X syndrome are reported.
Subjects and methods
Between 1991 and 1995, 19 fragile X families were newly identified by DNA mutation analysis of the FMR1 gene and were counselled at our department by one counsellor (BdV). In all families but one the index patient was male. The ages of the index patients at the time of diagnosis varied from 3 to 57 years. All the families remained in contact with our department for at least one year. Consultands were asked to inform relatives with an a priori risk of being a carrier of the fragile X syndrome about the possibility of counselling and DNA testing. To help them in this task, they could either use a brochure on the fragile X syndrome or give the telephone number of the clinical genetic service. The relatives who contacted the genetic service were subsequently informed about the a priori risk of being a carrier before testing. Relatives were divided into four groups based on their relationship to the fragile X patient: first, second, third, or fourth degree relatives. In each group the number of relatives informed about the risk by one of the primary consultands was determined based on information given by the family during the counselling process. The uptake of DNA mutation analysis and its result were evaluated. In addition to the interviews, the parents completed a questionnaire that assessed experience with the fragile X syndrome, attitude towards the fragile X syndrome, Impact of Event Scale (IES), the Beck Hopelessness Scale (BHS), and the Hospital Anxiety and Depression Scale (HAD). One female carrier did not complete the questionnaire because it provoked intrusive, unwanted feelings and one father because of language problems.
The Impact of Event Scale (IES) is a reliable, self report scale used to measure the current degree of subjective impact experienced as a result of a specific life event (in this case, fragile X syndrome).28 The IES estimates the influence of a stressor on two dimensions: (1) intrusion of unwanted ideas and thoughts into consciousness and (2) conscious denialavoidance. The IES consists of seven items that form the intrusion subscale (score range 0-35) and eight items that form the denial-avoidance subscale (score range 0-40).
The Beck Hopelessness Scale consists of 20 true/false statements used to measure hopelessness or the pessimistic expectations a person has for his/her future. A score of 9 or higher (range 0-20) is indicative of depression and possible suicidal behaviour.29 30 The Hospital Anxiety and Depression Scale is a self report instrument for screening for clinically significant anxiety and depression, and provides a valid measure of the severity of these mood disorders. A score above 10 on either scale (score range 0-21) is indicative of severe anxiety or depression.3'
Owing to the small sample size, the data from these questionnaires were not further analysed at a group level. However, scores on BHS and HAD were considered as indicative of psychological well being.
Results

UPTAKE OF DNA TEST AND TEST RESULTS
Up to the fourth degree, the 19 (12/14 parents) . One couple (both with extremely pessimistic future expectancies as measured by the BHS) hoped to survive their child. Another couple anticipated the future by developing a training programme to make their child more independent of them.
Experience after the diagnosis of the fragile X syndrome Long years of uncertainty, differing medical opinions, and guilt feelings were ended by the diagnosis. Moreover, the limitations of the child, his restless behaviour, and anxious moods were now confirmed as the reality.
Some couples (10/14) only communicated the test results and the clinical genetics department's offer of genetic counselling to their close relatives, while others (4/14) communicated the test result to relatives and were also able to inform and support them. A few couples (2/14) were afraid to burden relatives with the information and to provoke adverse reactions. Coping with the test result and informing relatives about the diagnosis and its hereditary aspects at the same time was regarded as a problem. Some reported resentment and disapproval by relatives (5/14), while most experienced positive reactions. Parents emphasised the need for additional support in regard to disclosure of the hereditary aspects to the family.
PSYCHOLOGICAL QUESTIONNAIRES
The most important result was the expression of relief (a cause was found) in 15/21 parents (table 3) . About half of the parents (11/21) stated that the diagnosis had improved their relationship with their affected child.
The impact of this diagnosis on relatives was generally acknowledged. The majority of the parents (18/21) informed close relatives within a few days of the diagnosis. The family's right to know about the genetics was generally acknowledged (20/2 1), including the responsibility to inform their relatives at risk (21/21) and to encourage them to be tested (20/21) (table 3). Half of the parents worried about the consequences of the result for their relatives and a quarter found it difficult to inform their relatives.
When asked, a minority (8/21) found pregnancy termination acceptable in the case of fragile X syndrome.
On the BHS, IES, and HAD questionnaires two couples and one single female carrier expressed great fear and pessimistic expectations. Both couples had BHS scores higher than 9 which indicates an increased risk of depression or possible suicidal behaviour. Three carriers had extremely high intrusion scores on the IES which reflects suffering from untoward feelings and thoughts about fragile X syndrome. Their HAD scores were higher than 10 indicating a severe depressive and anxious mood. Although the group is small, three out of 12 parents interviewed (25%) reported extreme psychological problems. No differences were observed between couples who experienced severe reactions and those who did not with respect to family structure and support.
Discussion
The diagnosis of the fragile X syndrome usually meant the end to a long period of uncertainty and anxiety among parents and disbelief by professionals. Parents were relieved and could adjust their expectations towards the affected child. However, little support was experienced, either from family or friends, or from professionals, especially for the problems associated with raising a mentally retarded child. Family life was strongly affected in different ways and nearly all parents expressed their worries about the future. Moreover, some participants reported severe psychological problems. Therefore, it is essential to pay attention to psychological support and follow up evaluation of the impact of a fragile X diagnosis.
Cascade screening within families in combination with counselling is a way to detect carriers and patients. In the present study, in more than half of the tested relatives mutations in the FMR1 gene (pre-or full mutation) were detected; however, on average, only one new fragile X patient and two additional carriers were diagnosed per index patient. The 
